Stifel Financial Corp Ardelyx, Inc. Transaction History
Stifel Financial Corp
- $91.8 Billion
- Q1 2025
A detailed history of Stifel Financial Corp transactions in Ardelyx, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 15,421 shares of ARDX stock, worth $86,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,421Holding current value
$86,357% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ARDX
# of Institutions
228Shares Held
169MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$140 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$98.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$89.8 Million0.0% of portfolio
-
Marshall Wace, LLP London, X011.3MShares$63 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$62.5 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...